Legence Corp. walks into its August 13 print with positioning that has flipped decisively bullish since the previous article published yesterday — the short retreat and call-heavy options skew described then remain in place, and the stock added another 5.7% on Wednesday to close at $68.68.
The options market is the clearest expression of current sentiment. The put/call ratio has held near 0.27 for several consecutive sessions — well below its 20-day average of 0.73 and roughly one standard deviation beneath its norm. That is the most call-dominated reading LGN has seen in months, a sharp reversal from late July when the PCR touched 1.24. Shorts continue to retreat alongside that call surge: SI has dropped 13.6% across the past week to 7.1% of the free float, down from around 6 million shares in mid-July to just over 4.2 million now. The borrow market offers no friction for either side — availability runs above 1,100% of current short interest, and cost to borrow remains near 0.50% despite a technical 45% weekly rise.
The analyst community is broadly constructive, though not uniformly so. Roth Capital reiterated its Buy rating and $120 target as recently as yesterday, and Guggenheim raised its target to $115 in early July. The bull case rests on record Q4 revenue of $737.6 million — up 34.6% year-over-year — a $1.5 billion backlog, and explosive Installation & Fabrication growth of 53%. Bears counter with a narrower argument: organic growth may disappoint relative to the headline numbers, Engineering & Design revenues already slipped slightly year-over-year, and fixed-fee contract exposure creates margin risk if costs overshoot. Barclays sits at Equal-Weight with an $80 target, a significant discount to the $106 consensus mean — itself sitting well above the current $68.68 price. The PE has compressed roughly 2.7 turns over the past month to 39x, while EV/EBITDA is near 10x, suggesting the market has already begun doing some of the valuation work ahead of the print.
Institutional flow adds a complicating layer. Blackstone — still the largest holder at 25% of shares — trimmed nearly 5.9 million shares in the June quarter. BlackRock moved the other way, adding 1.9 million shares. That divergence between the controlling financial sponsor reducing exposure and passive and active managers accumulating describes a market in transition: the IPO-era overhang is lightening, but new holders are stepping in at higher prices.
What the print will test is whether Legence's backlog and data-center-driven installation pipeline can deliver organic revenue growth at a pace that justifies the stock's near-50% year-to-date advance — especially given that the last two earnings events produced one-day drops of roughly 6% and 16% respectively.
See the live data behind this article on ORTEX.
Open LGN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
